Latest Trials


EudraCT Number: 2004-005184-15 Sponsor Protocol Number: 05_ENDO_46 Start Date: 2005-05-24
Sponsor Name: Christie Hospital NHS Trust
Full Title: Central Hypothyroidism and Adjusted Thyroxine dose Study (CHATS): impact of increasing free thyroxine levels in patients with hypopituitarism
Medical condition: Central (secondary/tertiary) hypothyroidism (subclinical)
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results

EudraCT Number: 2005-000380-26 Sponsor Protocol Number: CERTES02 (Ce-PoP-RAD001A2419) Start Date: 2005-05-24
Sponsor Name: Novartis Farmacéutica S.A.
Full Title: A 12 month, multicenter, randomized, parallel, open-label study, to evaluate renal function and efficacy of Certican® (everolimus) with Simulect® (basiliximab) and cyclosporine discontinuation at 3...
Medical condition: Renal Transplant
Disease: Version SOC Term Classification Code Term Level
M15 10023438
Population Age: Adults Gender: Male, Female
Trial protocol: ES (Completed)
Trial results: View results
EudraCT Number: 2005-000807-33 Sponsor Protocol Number: EFC5823 Start Date: 2005-05-24
Sponsor Name: sanofi-aventis recherche & développement
Full Title: Randomized, double-blind, two -arms placebo-controlled, parallel-group, multicenter study of rimonabant 20 mg once daily in the treatment of atherogenic dyslipidemia in abdominally obese patients.
Medical condition: Abdominally obese patients with atherogenic dyslipidemia
Disease: Version SOC Term Classification Code Term Level
7.1 10058110 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Completed) DK (Completed) IT (Completed)
Trial results: View results

EudraCT Number: 2005-001378-29 Sponsor Protocol Number: RAE02 Start Date: 2005-05-23
Sponsor Name: Bradford Teaching Hospitals NHS Foundation Trust
Full Title: A double blinded randomised controlled trial of injection of botulinum toxin versus normal saline into the puborectalis muscle in patients with pelvic floor dyssynergia.
Medical condition: Obstructed defeacation
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: (No results available)
EudraCT Number: 2004-004670-88 Sponsor Protocol Number: 4975-2-007-2 Start Date: 2005-05-23
Sponsor Name: AlgoRx Pharmaceuticals, Inc.
Full Title: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of ALGRX 4975 in Subjects after Inguinal Hernia Repair
Medical condition: Inguinal Hernia
Disease: Version SOC Term Classification Code Term Level
7.1 10022020 LLT
Population Age: Adults, Elderly Gender: Male
Trial protocol: DK (Ongoing)
Trial results: (No results available)

EudraCT Number: 2005-000867-24 Sponsor Protocol Number: ALFR-HC-04 Start Date: 2005-05-23
Sponsor Name: Human Genome Sciences, Inc.
Full Title: A PHASE 2b, RANDOMIZED, MULTI-CENTER, ACTIVE-CONTROLLED, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALBUFERON (RECOMBINANT HUMAN ALBUMIN-INTERFERON ALFA FUSION PROTEIN) IN COMBINATION...
Medical condition: Hepatitis type C chronic
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: DE (Completed) CZ (Completed)
Trial results: View results
EudraCT Number: 2004-002676-41 Sponsor Protocol Number: 100388,103494,104105,104106 Start Date: 2005-05-23
Sponsor Name: GlaxoSmithKline Biologicals
Full Title: Blinded, randomised, controlled, multicenter study to evaluate the clinical efficacy against varicella disease of GlaxoSmithKline Biologicals’ live attenuated varicella vaccine (Varilrix) given on ...
Medical condition: Healthy children between 12-22 months (including the day before the 23-month birthday) of age at the time of vaccination with no history of measles, mumps, rubella and varicella diseases/vaccination.
Disease: Version SOC Term Classification Code Term Level
14.1 10021881 - Infections and infestations 10028257 Mumps PT
14.1 10021881 - Infections and infestations 10046980 Varicella PT
14.1 10021881 - Infections and infestations 10039252 Rubella PT
14.1 10021881 - Infections and infestations 10027011 Measles PT
Population Age: Infants and toddlers, Under 18 Gender: Male, Female
Trial protocol: SE (Completed) LT (Completed) SK (Completed) CZ (Completed) IT (Completed)
Trial results: (No results available)

EudraCT Number: 2005-001774-27 Sponsor Protocol Number: AISSM03 Start Date: 2005-05-23
Sponsor Name: AISSM ONLUS
Full Title: CAMPATH-1H AS IMMUNOSUPPRESSIVE AGENT IN MDS PATIENTS MULTICENTRIC PILOT STUDY
Medical condition: In this study we want to assess the potential of CAMPATH-1H as an immunosuppressive agent in a series of selected MDS patients, because T lymphocytes are thought to play an important role in the ...
Disease: Version SOC Term Classification Code Term Level
6.1 10028536 HLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2004-004391-36 Sponsor Protocol Number: AC-052-402 Start Date: 2005-05-23
Sponsor Name: Actelion Pharmaceuticals Ltd.
Full Title: A multicenter, open-label, single-arm safety study to investigate the effects of chronic TRACLEER® treatment on testicular function in male patients with pulmonary arterial hypertension
Medical condition: Many endothelin receptor antagonists have profound effects on the histology and function of the testes in animals. These drugs have been shown to induce atrophy of the seminiferous tubules of the t...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male
Trial protocol: HU (Completed) CZ (Completed)
Trial results: View results

EudraCT Number: 2004-002096-16 Sponsor Protocol Number: 01/04 Start Date: 2005-05-23
Sponsor Name: Universitätskinderklinik Innsbruck
Full Title: Effect of plasma volume expansion with hydroxy-ethyl-starch (HES) 130/0.4 or crystalloids on interstitial fluid accumulation and blood pressure in newborn infants with arterial hypotension
Medical condition: Arterial hypotension
Disease: Version SOC Term Classification Code Term Level
Population Age: Preterm newborn infants, Newborns, Under 18 Gender: Male, Female
Trial protocol: AT (Ongoing)
Trial results: (No results available)
3